{
    "Rank": 451,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT00897962",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "234870"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "UCD-186"
                        },
                        {
                            "SecondaryId": "UCD-200614601"
                        },
                        {
                            "SecondaryId": "CDR0000583066",
                            "SecondaryIdType": "Other Identifier",
                            "SecondaryIdDomain": "UC Davis"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "University of California, Davis",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Blood Glycan Biomarkers in Women With Stage IV Breast Cancer",
                "OfficialTitle": "Serum Glycan Analysis in Breast Cancer"
            },
            "StatusModule": {
                "StatusVerifiedDate": "December 2018",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "September 2006"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "February 2011",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "January 12, 2016",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "May 9, 2009",
                "StudyFirstSubmitQCDate": "May 9, 2009",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "May 12, 2009",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "December 21, 2018",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "December 26, 2018",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "University of California, Davis",
                    "LeadSponsorClass": "OTHER"
                }
            },
            "OversightModule": {
                "OversightHasDMC": "Yes"
            },
            "DescriptionModule": {
                "BriefSummary": "RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur and identify biomarkers related to cancer.\n\nPURPOSE: This research study is looking at blood glycan biomarkers in women with stage IV breast cancer.",
                "DetailedDescription": "OBJECTIVES:\n\nTo profile serum glycan biomarkers in women with metastatic stage IV breast cancer, healthy controls, and patients with noncancer medical illness.\nTo determine whether serial serum glycan biomarkers correlate with response of metastatic disease to treatment.\n\nOUTLINE: This is a multicenter study.\n\nBlood is collected from patients with metastatic breast cancer, patients with noncancerous illness, and healthy volunteers. Samples are analyzed for serum glycan biomarkers by matrix-assisted laser desorption/ionization (MALDI) and Fourier transform ion-cyclotron resonance mass spectrometry (FT ICR MS) methods.\n\nBlood samples are collected every 3 months for up to 18 months from patients with metastatic breast cancer. Patients without cancer have a single sample collected."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Breast Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "stage IV breast cancer"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Other"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Other"
                        ]
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "163",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Metastatic Breast Cancer",
                            "ArmGroupDescription": "Patients with metastatic breast cancer receiving treatment with chemotherapy, endocrine therapy or targeted therapy",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Other: Metastatic Breast Cancer"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "Non-cancer medical illness",
                            "ArmGroupDescription": "Patients with non-cancer medical condition",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Other: Non-cancer medical illness"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "Healthy Controls",
                            "ArmGroupDescription": "Healthy patients being seen for an annual exam",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Other: Healthy Controls"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Healthy Controls",
                            "InterventionDescription": "One blood draw (2 teaspoons)",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Healthy Controls"
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Metastatic Breast Cancer",
                            "InterventionDescription": "Blood samples will be drawn every 3 months, for up to 18 months.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Metastatic Breast Cancer"
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Non-cancer medical illness",
                            "InterventionDescription": "One blood draw (2 teaspoons)",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Non-cancer medical illness"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Profiling serum glycan biomarkers in patients with metastatic breast cancer, healthy controls, and patients with noncancer medical illness",
                            "PrimaryOutcomeTimeFrame": "up to 18 months"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Predictability of serial serum biomarkers in determining disease response and/or progression",
                            "SecondaryOutcomeTimeFrame": "Up to 18 months"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "DISEASE CHARACTERISTICS:\n\nPatient or participant at the Women's Health Clinic, the Internal Medicine Clinic, or at the UC Davis Cancer Center, meeting 1 of the following criteria:\n\nDiagnosis of stage IV metastatic breast cancer, receiving active treatment with chemotherapy, endocrine therapy, or targeted therapy\n\nPatients/participants without cancer\n\nHealthy control being seen for annual exams, meeting the following criteria:\n\nNo chronic disease\nNot on regular prescribed medications\nPatient without cancer being seen in the Internal Medicine Clinic\nHormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\nMenopausal status not specified\nNot pregnant or breast feeding\nNo other active cancer\n\nPRIOR CONCURRENT THERAPY:\n\nSee Disease Characteristics",
                "HealthyVolunteers": "Accepts Healthy Volunteers",
                "Gender": "Female",
                "MinimumAge": "18 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Patients with metastatic breast cancer receiving active chemotherapy, endocrine therapy or targeted therapy Healthy age matched controls without chronic diseases and not on regular prescription medications Patients seen at Internal Medicine Clinic for any reason other than active, metastatic cancer",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Helen K. Chew, MD",
                            "OverallOfficialAffiliation": "University of California, Davis",
                            "OverallOfficialRole": "Study Chair"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "University of California Davis Cancer Center",
                            "LocationCity": "Sacramento",
                            "LocationState": "California",
                            "LocationZip": "95817",
                            "LocationCountry": "United States"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000001943",
                            "ConditionMeshTerm": "Breast Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000001941",
                            "ConditionAncestorTerm": "Breast Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012871",
                            "ConditionAncestorTerm": "Skin Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M4910",
                            "ConditionBrowseLeafName": "Breast Neoplasms",
                            "ConditionBrowseLeafAsFound": "Breast Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M4908",
                            "ConditionBrowseLeafName": "Breast Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M15364",
                            "ConditionBrowseLeafName": "Skin Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC17",
                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            }
        }
    }
}